Texas Court throws out breast implant award:
This article was originally published in Clinica
A US Appeals Court has reversed a decision which awarded four women $1.5 million in a breast implant judgment against 3M. The court found that the women's expert scientific witnesses "...were either unqualified to give a conclusion as to causation, or the qualified experts based their conclusions on unreliable evidence". The women will now get nothing.
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.